SARAH ROBERTSON: Open Payments
NPI 1356690234 · PALMDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 27 payments from 19 companies in 2025. Trend: 2023 $1,457 · 2024 $1,003 · 2025 $668
Food & beverage: $668
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 4 | $130 |
| Astellas Pharma US Inc | 2 | $55 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| Amgen Inc. | 3 | $51 |
| TOLMAR, INC. | 2 | $39 |
| Eisai Inc. | 1 | $33 |
| Lilly USA, LLC | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Verity Pharmaceuticals Inc. | 1 | $29 |
| PFIZER INC. | 1 | $28 |
Products named: Dexcom G6 Transmitter, Veozah, VERQUVO, OTEZLA, JATENZO, Leqembi, MOUNJARO, DUPIXENT.
Industry payments across CA — which companies pay providers there.
